Danaher Co. Announces Quarterly Dividend of $0.27 (NYSE:DHR)

Danaher Co. (NYSE:DHR) declared a quarterly dividend on Tuesday, December 10th,RTT News reports. Shareholders of record on Friday, December 27th will be paid a dividend of 0.27 per share by the conglomerate on Friday, January 31st. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%.

Danaher has increased its dividend payment by an average of 13.4% annually over the last three years. Danaher has a dividend payout ratio of 12.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Danaher to earn $8.38 per share next year, which means the company should continue to be able to cover its $1.08 annual dividend with an expected future payout ratio of 12.9%.

Danaher Price Performance

Shares of NYSE DHR traded down $1.57 during midday trading on Tuesday, reaching $234.34. The company’s stock had a trading volume of 2,694,170 shares, compared to its average volume of 2,778,684. The company has a market cap of $169.26 billion, a P/E ratio of 44.72, a P/E/G ratio of 4.23 and a beta of 0.83. Danaher has a fifty-two week low of $217.96 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The business’s 50 day moving average price is $249.91 and its two-hundred day moving average price is $258.14.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.02 earnings per share. On average, analysts forecast that Danaher will post 7.5 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. UBS Group lowered their price target on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Wells Fargo & Company began coverage on shares of Danaher in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 target price for the company. Evercore ISI lifted their price target on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Robert W. Baird dropped their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Finally, Barclays decreased their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.